{"id":4972,"date":"2026-05-26T06:07:50","date_gmt":"2026-05-26T06:07:50","guid":{"rendered":"https:\/\/trg.unhas.ac.id\/natural-drug\/?p=4972"},"modified":"2026-05-26T06:09:45","modified_gmt":"2026-05-26T06:09:45","slug":"breathing-hope-a-new-clue-in-predicting-deadly-lung-scarring","status":"publish","type":"post","link":"https:\/\/trg.unhas.ac.id\/natural-drug\/2026\/05\/26\/breathing-hope-a-new-clue-in-predicting-deadly-lung-scarring\/","title":{"rendered":"Breathing Hope: A New Clue in Predicting Deadly Lung Scarring"},"content":{"rendered":"\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-1af245882584cc1241f3414f17f224ca wp-block-paragraph\">What if a simple blood marker could help doctors predict how fast a deadly lung disease is progressing? A recent scientific discovery may bring us one step closer to that possibility.<\/p>\n\n\n\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-e0dd14672bce0037327b771cf3a6cdae wp-block-paragraph\">A study titled&nbsp;<em>\u201cOsteoprotegerin Is Elevated in Pulmonary Fibrosis and Associates with Idiopathic Pulmonary Fibrosis Progression: A Pilot Study\u201d<\/em>, published in the journal&nbsp;<em>Respiration<\/em>&nbsp;by&nbsp;<strong>S. Karger AG<\/strong>&nbsp;on&nbsp;<strong>13 August 2025<\/strong>, explored an important biological signal that could improve how doctors understand and monitor a severe lung disease called idiopathic pulmonary fibrosis (IPF).<\/p>\n\n\n\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-e3be15445beaf78ff1a5776a4478ad0e wp-block-paragraph\">IPF is a chronic and progressive disease in which lung tissue becomes scarred over time. As the lungs stiffen, breathing becomes increasingly difficult, making everyday activities such as walking or climbing stairs exhausting. Unfortunately, many patients are diagnosed late because symptoms are often mistaken for normal aging or common respiratory problems. Worse still, predicting how quickly the disease will worsen remains a major challenge.<\/p>\n\n\n\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-b9ed6cdbcb7fbcb65b07dc6cfae472eb wp-block-paragraph\">In this pilot study, researchers investigated a molecule called&nbsp;<strong>osteoprotegerin (OPG)<\/strong>. Although OPG is usually known for its role in bone health, scientists discovered that it may also be involved in lung scarring. The researchers found significantly higher levels of OPG in fibrotic lung tissue and in the blood of patients with IPF compared with healthy individuals. Even more importantly, patients with higher OPG levels tended to experience faster disease progression and poorer lung function.<\/p>\n\n\n\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-9362ca90b233d8713a511695f2c0bcd3 wp-block-paragraph\">The findings suggest that OPG may serve as a&nbsp;<strong>biomarker<\/strong>\u2014a measurable biological sign that helps doctors identify disease severity and predict outcomes. Imagine a future where physicians can use a blood test not only to diagnose lung fibrosis earlier but also to estimate whether a patient is at higher risk of rapid deterioration. Such information could help guide treatment decisions and improve patient care.<\/p>\n\n\n\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-11f005408e1d6f5a2b1056d1b9e342d1 wp-block-paragraph\">This scientific advancement strongly connects with&nbsp;<strong>SDG 3: Good Health and Well-Being<\/strong>, which aims to ensure healthy lives and promote well-being for all. Better biomarkers can lead to earlier diagnosis, more personalized treatment, and improved survival for people living with chronic respiratory diseases. By identifying patients who need urgent intervention, healthcare systems may become more effective in reducing suffering and mortality from lung diseases.<\/p>\n\n\n\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-e094b793072ea9ed23f284db52025f0b wp-block-paragraph\">At the same time, this research reflects the spirit of&nbsp;<strong>SDG 17: Partnerships for the Goals<\/strong>. The study involved international collaboration among researchers from multiple countries and institutions, including Indonesia, the Netherlands, Germany, Australia, and the United States. Such partnerships demonstrate that solving global health problems requires cooperation across borders, expertise, and scientific disciplines.<\/p>\n\n\n\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-199b1246050173b3de2ac124a6785b2a wp-block-paragraph\">The article itself serves as an inspiring example of how international scientific teamwork can contribute to medical breakthroughs. By combining expertise in pharmacy, pulmonary medicine, pathology, and molecular biology, researchers were able to uncover new insights into one of the world\u2019s most devastating lung diseases.<\/p>\n\n\n\n<p class=\"has-palette-color-4-color has-text-color has-link-color wp-elements-127494790a3bcbffd4c1adb81a517d81 wp-block-paragraph\">Although larger studies are still needed before OPG can be widely used in hospitals, this research offers something invaluable:&nbsp;<strong>hope<\/strong>. For patients struggling to breathe, even a small scientific breakthrough can represent a giant step toward a healthier future. After all, every breath matters\u2014and science continues working to protect it.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>What if a simple blood marker could help doctors predict how fast a deadly lung disease is progressing? A recent scientific discovery may bring us one step closer to that possibility. A study titled&nbsp;\u201cOsteoprotegerin Is Elevated in Pulmonary Fibrosis and Associates with Idiopathic Pulmonary Fibrosis Progression: A Pilot Study\u201d, published in the journal&nbsp;Respiration&nbsp;by&nbsp;S. Karger AG&nbsp;on&nbsp;13 [&hellip;]<\/p>\n","protected":false},"author":209,"featured_media":4974,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[1],"tags":[46,32],"class_list":["post-4972","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-sdg17","tag-sdg3"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59.png",1560,670,false],"thumbnail":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-150x150.png",150,150,true],"medium":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-300x129.png",300,129,true],"medium_large":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-768x330.png",768,330,true],"large":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-1024x440.png",1024,440,true],"1536x1536":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-1536x660.png",1536,660,true],"2048x2048":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59.png",1560,670,false]},"uagb_author_info":{"display_name":"adminnatural-drug","author_link":"https:\/\/trg.unhas.ac.id\/natural-drug\/author\/adminnatural-drug\/"},"uagb_comment_info":0,"uagb_excerpt":"What if a simple blood marker could help doctors predict how fast a deadly lung disease is progressing? A recent scientific discovery may bring us one step closer to that possibility. A study titled&nbsp;\u201cOsteoprotegerin Is Elevated in Pulmonary Fibrosis and Associates with Idiopathic Pulmonary Fibrosis Progression: A Pilot Study\u201d, published in the journal&nbsp;Respiration&nbsp;by&nbsp;S. Karger AG&nbsp;on&nbsp;13&hellip;","rttpg_featured_image_url":{"full":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59.png",1560,670,false],"landscape":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59.png",1560,670,false],"portraits":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59.png",1560,670,false],"thumbnail":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-150x150.png",150,150,true],"medium":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-300x129.png",300,129,true],"large":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-1024x440.png",1024,440,true],"1536x1536":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59-1536x660.png",1536,660,true],"2048x2048":["https:\/\/trg.unhas.ac.id\/natural-drug\/wp-content\/uploads\/sites\/243\/2026\/05\/Screenshot-2026-05-26-at-14.08.59.png",1560,670,false]},"rttpg_author":{"display_name":"adminnatural-drug","author_link":"https:\/\/trg.unhas.ac.id\/natural-drug\/author\/adminnatural-drug\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/trg.unhas.ac.id\/natural-drug\/category\/uncategorized\/\" rel=\"category tag\">Uncategorized<\/a>","rttpg_excerpt":"What if a simple blood marker could help doctors predict how fast a deadly lung disease is progressing? A recent scientific discovery may bring us one step closer to that possibility. A study titled&nbsp;\u201cOsteoprotegerin Is Elevated in Pulmonary Fibrosis and Associates with Idiopathic Pulmonary Fibrosis Progression: A Pilot Study\u201d, published in the journal&nbsp;Respiration&nbsp;by&nbsp;S. Karger AG&nbsp;on&nbsp;13&hellip;","_links":{"self":[{"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/posts\/4972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/users\/209"}],"replies":[{"embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/comments?post=4972"}],"version-history":[{"count":1,"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/posts\/4972\/revisions"}],"predecessor-version":[{"id":4973,"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/posts\/4972\/revisions\/4973"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/media\/4974"}],"wp:attachment":[{"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/media?parent=4972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/categories?post=4972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/natural-drug\/wp-json\/wp\/v2\/tags?post=4972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}